{"schema_version":"1","generated_at":"2026-10-29T11:30:48.048Z","data_as_of":null,"url":"https://www.findmykol.com/kol/frank-mott","json_url":"https://www.findmykol.com/kol/frank-mott/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"frank-mott","name":"Frank Mott","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas MD Anderson Cancer Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-md-anderson-cancer-center","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1043270416","orcid":"0000-0003-2963-5328","openalex":"A5050140548"},"summary":"Frank Mott is an Oncology physician affiliated with The University of Texas MD Anderson Cancer Center. OpenAlex indexes 138 publications with 3,611 citations (h-index 24).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":138,"cited_by_count":3611,"h_index":24,"latest_activity_year":2024,"source":"works"},"prescribing":{"data_year":2022,"areas_total":2,"areas_shown":2,"areas":[{"area":"Sensory organs","share_pct":50,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":50,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":50,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":50,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":11}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors","year":2024,"journal":"The Oncologist","source_url":"https://doi.org/10.1093/oncolo/oyad338","status":"verified"},{"title":"Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.22.02221","status":"verified"},{"title":"Immuno-chemotherapy as single treatment modality for larynx preservation (ICoLP): Co-primary endpoints and safety results.","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2023.41.16_suppl.6008","status":"verified"},{"title":"Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature","year":2023,"journal":"Journal of Immunotherapy and Precision Oncology","source_url":"https://doi.org/10.36401/jipo-22-30","status":"verified"},{"title":"Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer","year":2023,"journal":"Cancer","source_url":"https://doi.org/10.1002/cncr.34820","status":"verified"}],"source":"works"},"contact":{"address_1":"1515 HOLCOMBE BLVD","city":"Houston","state":"TX","zip":"770304000","phone":"713-792-6161","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1043270416","source":"identity"},"similar":[{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Jaffer Ajani","slug":"jaffer-ajani","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jaffer-ajani","json_url":"https://www.findmykol.com/kol/jaffer-ajani/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-12-30","provider_certified":"2020-12-30","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}